CIK 0000025743 · Non-accelerated filer<br>Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 870233535
- Phone
- 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-23 | Thompson Tommy G Director | Purchase | +8,400 | $1.67 | $14K | 23,179 |
| 2025-11-03 | Thompson Tommy G Director | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2025-11-03 | Naughton Gail K Director | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2025-11-03 | Collins Cooper C. Director | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2025-11-03 | Walker Marlan D Chief Executive Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +67,492 | 67,492 | ||
| 2025-04-14 | Thompson Tommy G Director | Purchase | +325 | $1.00 | $326 | 14,779 |
| 2025-04-14 | Walker Marlan D Chief Executive Officer | Purchase | +490 | $1.00 | $489 | 73,639 |
| 2025-04-10 | Walker Marlan D Chief Executive Officer | Purchase | +1,167 | $0.86 | $1K | 73,149 |
| 2025-04-09 | Walker Marlan D Chief Executive Officer | Purchase | +1,136 | $0.87 | $994 | 71,982 |
| 2025-02-18 | Collins Cooper C. Director | Option exercise | +8,500 | 60,516 | ||
| 2025-02-18 | Collins Cooper C. Director | Option exercise · Restricted Stock Units | −8,500 | 0 | ||
| 2025-02-18 | Naughton Gail K Director | Option exercise | +8,500 | 8,500 | ||
| 2025-02-18 | Naughton Gail K Director | Option exercise · Restricted Stock Units | −8,500 | 0 | ||
| 2025-02-18 | Thompson Tommy G Director | Option exercise | +8,500 | 14,454 | ||
| 2025-02-18 | Thompson Tommy G Director | Option exercise · Restricted Stock Units | −8,500 | 0 | ||
| 2025-02-18 | Walker Marlan D Chief Executive Officer | Option exercise | +3,467 | 66,032 | ||
| 2025-02-18 | Walker Marlan D Chief Executive Officer | Option exercise | +2,311 | 68,343 | ||
| 2025-02-18 | Walker Marlan D Chief Executive Officer | Option exercise | +770 | 69,113 | ||
| 2025-02-18 | Walker Marlan D Chief Executive Officer | Option exercise | +1,733 | 70,846 | ||
| 2025-02-18 | Walker Marlan D Chief Executive Officer | Option exercise · Performance Stock Units | −3,467 | 0 |
Page 1 of 11 · 206 trades